Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$3.7M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 12 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 38 most recent Form 4 transactions.
| $202.4K |
| -23.7% |
| Open the original filing on SEC.gov |
| Sep 16 | AVTX | Avalo Therapeutics, Inc. | MEXER◷ | 12,394 | $9.88 | $122.5K | +31.1% | Open the original filing on SEC.gov |
| Sep 10 | AVTX | Avalo Therapeutics, Inc. | MEXER◷◆ | 10,185 | — | — | — | Open the original filing on SEC.gov |
| Sep 10 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 10,185 | $17.62 | $179.5K | -20.3% | Open the original filing on SEC.gov |
| Sep 10 | AVTX | Avalo Therapeutics, Inc. | MEXER◷ | 10,185 | $8.04 | $81.9K | +25.5% | Open the original filing on SEC.gov |
| Aug 18 | AVTX | Avalo Therapeutics, Inc. | MEXER◷◆ | 31,031 | — | — | — | Open the original filing on SEC.gov |
| Aug 18 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 31,031 | $20.05 | $622.3K | -43.8% | Open the original filing on SEC.gov |
| Aug 18 | AVTX | Avalo Therapeutics, Inc. | MEXER◷ | 31,031 | $9.88 | $306.6K | +77.8% | Open the original filing on SEC.gov |
| Aug 17 | AVTX | Avalo Therapeutics, Inc. | MEXER◷◆ | 2,876 | — | — | — | Open the original filing on SEC.gov |
| Aug 17 | AVTX | Avalo Therapeutics, Inc. | MEXER◷◆ | 37,945 | — | — | — | Open the original filing on SEC.gov |
| Aug 17 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 3,749 | $19.94 | $74.8K | -8.6% | Open the original filing on SEC.gov |
| Aug 17 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 37,945 | $19.85 | $753.3K | -46.5% | Open the original filing on SEC.gov |
| Aug 17 | AVTX | Avalo Therapeutics, Inc. | MEXER◷ | 2,876 | $9.88 | $28.4K | +3.6% | Open the original filing on SEC.gov |
| Aug 17 | AVTX | Avalo Therapeutics, Inc. | MEXER◷ | 37,945 | $9.88 | $374.9K | +93.1% | Open the original filing on SEC.gov |
| Jun 10 | AVTX | Avalo Therapeutics, Inc. | FTAX | 138 | $13.10 | $1.8K | -0.3% | Open the original filing on SEC.gov |
| May 21 | AVTX | Avalo Therapeutics, Inc. | AGRANT | 39,900 | — | — | +9,433% | Open the original filing on SEC.gov |
| May 7 | AVTX | Avalo Therapeutics, Inc. | MEXER◷◆ | 18,606 | — | — | — | Open the original filing on SEC.gov |
| May 7 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 18,606 | $24.12 | $448.8K | -97.8% | Open the original filing on SEC.gov |
| May 7 | AVTX | Avalo Therapeutics, Inc. | MEXER◷ | 18,606 | $9.88 | $183.8K | +4,399% | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | MEXER◷◆ | 47,000 | — | — | — | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 8,900 | $22.57 | $200.9K | -95.5% | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 9,219 | $21.37 | $197K | -49.7% | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 2,700 | $20.76 | $56.1K | -12.7% | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 12,347 | $19.28 | $238.1K | -36.8% | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 13,834 | $18.55 | $256.7K | -29.2% | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | MEXER◷ | 47,000 | $8.04 | $377.9K | +11,111% | Open the original filing on SEC.gov |
| Apr 30 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 8,457 | $13.23 | $111.9K | -95.2% | Open the original filing on SEC.gov |
| Apr 29 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 8,458 | $13.09 | $110.7K | -48.8% | Open the original filing on SEC.gov |
| Apr 2 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 1,780 | $17.57 | $31.3K | -9.3% | Open the original filing on SEC.gov |
| Apr 2 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 6,200 | $17.02 | $105.6K | -24.5% | Open the original filing on SEC.gov |
| Apr 1 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 7,479 | $16.83 | $125.8K | -22.8% | Open the original filing on SEC.gov |
| Apr 1 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 500 | $15.86 | $7.9K | -1.5% | Open the original filing on SEC.gov |
| Mar 28 | AVTX | Avalo Therapeutics, Inc. | MEXER◆ | 24,200 | — | — | — | Open the original filing on SEC.gov |
| Mar 28 | AVTX | Avalo Therapeutics, Inc. | FTAX | 8,241 | $13.89 | $114.5K | -19.8% | Open the original filing on SEC.gov |
| Mar 28 | AVTX | Avalo Therapeutics, Inc. | MEXER | 24,200 | — | — | +139.6% | Open the original filing on SEC.gov |
| Feb 26 | AVTX | Avalo Therapeutics, Inc. | AGRANT◆ | 105,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 10, 2025 | AVTX | Avalo Therapeutics, Inc. | FTAX | 155 | $4.10 | $636 | -0.9% | Open the original filing on SEC.gov |